KYMR
Price
$44.79
Change
+$0.26 (+0.58%)
Updated
Jul 3 closing price
Capitalization
3.14B
26 days until earnings call
VERA
Price
$24.00
Change
+$0.35 (+1.48%)
Updated
Jul 3 closing price
Capitalization
1.53B
32 days until earnings call
Interact to see
Advertisement

KYMR vs VERA

Header iconKYMR vs VERA Comparison
Open Charts KYMR vs VERABanner chart's image
Kymera Therapeutics
Price$44.79
Change+$0.26 (+0.58%)
Volume$240.49K
Capitalization3.14B
Vera Therapeutics
Price$24.00
Change+$0.35 (+1.48%)
Volume$629.76K
Capitalization1.53B
KYMR vs VERA Comparison Chart in %
Loading...
KYMR
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
VERA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
KYMR vs. VERA commentary
Jul 06, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is KYMR is a Buy and VERA is a StrongBuy.

Interact to see
Advertisement
COMPARISON
Comparison
Jul 06, 2025
Stock price -- (KYMR: $44.79 vs. VERA: $24.00)
Brand notoriety: KYMR and VERA are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: KYMR: 25% vs. VERA: 31%
Market capitalization -- KYMR: $3.14B vs. VERA: $1.53B
KYMR [@Biotechnology] is valued at $3.14B. VERA’s [@Biotechnology] market capitalization is $1.53B. The market cap for tickers in the [@Biotechnology] industry ranges from $310.37B to $0. The average market capitalization across the [@Biotechnology] industry is $2.38B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

KYMR’s FA Score shows that 0 FA rating(s) are green whileVERA’s FA Score has 0 green FA rating(s).

  • KYMR’s FA Score: 0 green, 5 red.
  • VERA’s FA Score: 0 green, 5 red.
According to our system of comparison, VERA is a better buy in the long-term than KYMR.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

KYMR’s TA Score shows that 4 TA indicator(s) are bullish while VERA’s TA Score has 5 bullish TA indicator(s).

  • KYMR’s TA Score: 4 bullish, 4 bearish.
  • VERA’s TA Score: 5 bullish, 4 bearish.
According to our system of comparison, VERA is a better buy in the short-term than KYMR.

Price Growth

KYMR (@Biotechnology) experienced а -2.01% price change this week, while VERA (@Biotechnology) price change was +2.96% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +6.30%. For the same industry, the average monthly price growth was +17.40%, and the average quarterly price growth was -0.11%.

Reported Earning Dates

KYMR is expected to report earnings on Aug 01, 2025.

VERA is expected to report earnings on Aug 07, 2025.

Industries' Descriptions

@Biotechnology (+6.30% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
KYMR($3.14B) has a higher market cap than VERA($1.53B). KYMR YTD gains are higher at: 11.335 vs. VERA (-43.249). VERA has higher annual earnings (EBITDA): -167.77M vs. KYMR (-232.67M). VERA has more cash in the bank: 590M vs. KYMR (463M). VERA has less debt than KYMR: VERA (54.5M) vs KYMR (86.3M). KYMR has higher revenues than VERA: KYMR (58.9M) vs VERA (0).
KYMRVERAKYMR / VERA
Capitalization3.14B1.53B205%
EBITDA-232.67M-167.77M139%
Gain YTD11.335-43.249-26%
P/E RatioN/AN/A-
Revenue58.9M0-
Total Cash463M590M78%
Total Debt86.3M54.5M158%
TECHNICAL ANALYSIS
Technical Analysis
KYMRVERA
RSI
ODDS (%)
Bearish Trend 4 days ago
90%
Bearish Trend 4 days ago
78%
Stochastic
ODDS (%)
Bullish Trend 4 days ago
88%
Bearish Trend 4 days ago
89%
Momentum
ODDS (%)
Bearish Trend 4 days ago
87%
Bullish Trend 4 days ago
86%
MACD
ODDS (%)
Bearish Trend 4 days ago
81%
Bullish Trend 4 days ago
88%
TrendWeek
ODDS (%)
Bearish Trend 4 days ago
87%
Bullish Trend 4 days ago
88%
TrendMonth
ODDS (%)
Bullish Trend 4 days ago
83%
Bearish Trend 4 days ago
84%
Advances
ODDS (%)
Bullish Trend 4 days ago
85%
Bullish Trend 4 days ago
86%
Declines
ODDS (%)
Bearish Trend 7 days ago
88%
Bearish Trend 10 days ago
83%
BollingerBands
ODDS (%)
Bullish Trend 4 days ago
85%
Bearish Trend 4 days ago
81%
Aroon
ODDS (%)
N/A
N/A
View a ticker or compare two or three
Interact to see
Advertisement
KYMR
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
VERA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
USLYX72.170.77
+1.08%
JHancock U.S. Global Leaders Growth R2
PLAAX16.110.17
+1.07%
PACE Large Co Growth Equity A
SGAPX24.750.24
+0.98%
Virtus SGA Global Growth I
DHFYX13.960.06
+0.43%
Diamond Hill Large Cap Concentrated Y
PRIKX15.41N/A
N/A
T. Rowe Price Real Assets I

KYMR and

Correlation & Price change

A.I.dvisor indicates that over the last year, KYMR has been closely correlated with NRIX. These tickers have moved in lockstep 66% of the time. This A.I.-generated data suggests there is a high statistical probability that if KYMR jumps, then NRIX could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To KYMR
1D Price
Change %
KYMR100%
+0.58%
NRIX - KYMR
66%
Closely correlated
+2.33%
CCCC - KYMR
57%
Loosely correlated
-2.63%
CGON - KYMR
54%
Loosely correlated
+0.82%
VERA - KYMR
54%
Loosely correlated
+1.48%
RVMD - KYMR
53%
Loosely correlated
+1.83%
More

VERA and

Correlation & Price change

A.I.dvisor indicates that over the last year, VERA has been loosely correlated with KYMR. These tickers have moved in lockstep 54% of the time. This A.I.-generated data suggests there is some statistical probability that if VERA jumps, then KYMR could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To VERA
1D Price
Change %
VERA100%
+1.48%
KYMR - VERA
54%
Loosely correlated
+0.58%
LYRA - VERA
54%
Loosely correlated
-3.33%
OPORF - VERA
50%
Loosely correlated
N/A
BPMC - VERA
47%
Loosely correlated
+0.12%
BNTX - VERA
40%
Loosely correlated
+1.61%
More